Dipal Doshi

CEO at Entrada Therapeutics · 5 reported transactions in 2 companies · latest report Mar 3, 2026

Their trades


Entrada TherapeuticsTRDA	Shares withheld for tax $225.5K · 19,181 shares	Mar 3, 2026
Entrada TherapeuticsTRDA	Shares withheld for tax $115.1K · 9,869 shares	Mar 2, 2026
Entrada TherapeuticsTRDA	Share award — · 139,400 shares	Mar 1, 2026
AzentaAZTA	Share award $157.7K · 5,663 shares	Feb 5, 2026
Entrada TherapeuticsTRDA	Shares withheld for tax $47.4K · 8,723 shares	Sep 2, 2025

Shares withheld for taxEntrada Therapeutics

Mar 3, 2026 · TRDA

$225.5K

Shares withheld for taxEntrada Therapeutics

Mar 2, 2026 · TRDA

$115.1K

Mar 1, 2026 · TRDA

139,400

Share awardAzenta

Feb 5, 2026 · AZTA

$157.7K

Shares withheld for taxEntrada Therapeutics

Sep 2, 2025 · TRDA

$47.4K

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

CEO at Entrada Therapeutics · 5 reported transactions in 2 companies · latest report Mar 3, 2026


Entrada TherapeuticsTRDA	Shares withheld for tax $225.5K · 19,181 shares	Mar 3, 2026
Entrada TherapeuticsTRDA	Shares withheld for tax $115.1K · 9,869 shares	Mar 2, 2026
Entrada TherapeuticsTRDA	Share award — · 139,400 shares	Mar 1, 2026
AzentaAZTA	Share award $157.7K · 5,663 shares	Feb 5, 2026
Entrada TherapeuticsTRDA	Shares withheld for tax $47.4K · 8,723 shares	Sep 2, 2025

Shares withheld for taxEntrada Therapeutics

Mar 3, 2026 · TRDA

$225.5K

Shares withheld for taxEntrada Therapeutics

Mar 2, 2026 · TRDA

$115.1K

Mar 1, 2026 · TRDA

139,400

Share awardAzenta

Feb 5, 2026 · AZTA

$157.7K

Shares withheld for taxEntrada Therapeutics

Sep 2, 2025 · TRDA

$47.4K

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.